Early phase 1Recruiting

Effect of Neural Constraints on Movement in Stroke (ENCMS)

Sponsor
Northwestern University (Academic or other)
Enrolment
64 planned
Conditions
Stroke
Interventions
Tizanidine; Placebo
Ages
adults, older adults
Registry
NCT06666673

From the registry

This study investigates the effects of Tizanidine on the voluntary movement controls of the arms of participants who have had a stroke and have not had a stroke by measuring medication-induced changes in upper extremity kinematics, pupillometry, and brain activity. Tizanidine is approved by the U.S. Food and Drug Administration. Understanding how different areas of the brain are involved in movement impairments may help rehabilitation efforts and assist in restoring healthy movement in individuals who have had a stroke.

Primary outcomes

  • Brace Height
  • Cortico-muscular-coherence in beta band
  • Difference in reaching distance under shoulder abduction load
  • Reflexive electromyograph activity prior to movement
Full record on ClinicalTrials.gov